GlaxoSmithKline Pharmaceuticals Ltd

📅 GSK Pharma Board Meeting Set for May 13, 2026 to Review FY26 Results & Potential Dividend

- Board meeting scheduled for May 13, 2026

- Approval of audited standalone and consolidated financial results for the year ended March 31, 2026

- Potential recommendation of dividend on equity shares to be considered